While the role of inflammasome activation in neurological disorders is increasingly emerging, we here demonstrate that aggregated Tau activates the NLRP3–ASC inflammasome, providing a compelling molecular mechanism for the close and invariable association of microglial changes and Tau pathology in Tauopathies. The gene discussed is MAPT; the disease is tauopathy.